Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results

Genomic technologies can be applied in all phases of the drug development process. In the last of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the impact of genomic technologies from early research and development and discovery to clinical development.  In addition he explains why the adoption of genomic technologies is important throughout the project lifecycle. Watch part three Related Services: Anatomic Pathology Services Biomarker Services Central Laboratories Companion Diagnostics Genomic Laboratories Precision Medicine

Topics

Genomics , Precision Medicine , Companion Diagnostics

Genomic technologies have been widely adopted within oncology, according to Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions. In the second video from a three-part series, Hurban discusses the use of genomics in oncology trials and many other therapeutic areas as well. Watch Part two Related Services: Anatomic Pathology Services Biomarker Services Central Laboratories Companion Diagnostics Genomic Laboratories Precision Medicine

Topics

Companion Diagnostics , Genomics , Precision Medicine

In part one of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the significance of genomic technologies in clinical trials. Dr. Hurban shares his perspective on genomic technologies and the future of precision medicine as well as how both will impact healthcare globally. Watch Part one

Topics

Companion Diagnostics , Genomics , Precision Medicine